NewGenIvf adds director, reports no share stake

NewGenIvf Group Ltd disclosed a late Form 3 for a new independent non-executive director, with no company securities reported as held.

Rhea-AI Filing Summary

NewGenIvf Group Ltd (NIVF) reported the initial beneficial ownership status of newly appointed independent non-executive director Lau Tsz Hin Vincent on a Form 3. The filing does not report any holdings or transactions in NewGenIvf securities by this director as of the report. The company explains the Form 3 was filed late due to administrative and logistical delays related to remote/foreign notarization and obtaining EDGAR access credentials.

Key Figures

Appointment date as Independent Non-Executive Director: June 8, 2026 Reported share transactions: 0 shares Holding entries reported: 0 holdings

3 metrics

Appointment date as Independent Non-Executive Director June 8, 2026 Date the Reporting Person was appointed to the board

Reported share transactions 0 shares No buy, sell, acquire, dispose, or derivative transactions reported on the Form 3

Holding entries reported 0 holdings Form 3 lists no existing holdings of NewGenIvf Group Ltd securities

Key Terms

Independent Non-Executive Director, Form 3, EDGAR access credentials, remote/foreign notarization

4 terms

Independent Non-Executive Director regulatory

"The Reporting Person was appointed as an Independent Non-Executive Director on June 8, 2026"

An independent non-executive director is a board member who is not part of a company’s day-to-day management and has no close ties to major owners, so they can offer unbiased oversight of strategy, risks, and executive pay. For investors, they act like an impartial referee who helps prevent conflicts of interest, improve transparency and hold management accountable, which can reduce governance risk and protect shareholder value.

Form 3 regulatory

"This Form 3 is being filed late due to administrative and logistical delays"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

EDGAR access credentials regulatory

"processing the initial EDGAR access credentials (Form ID) for the newly appointed Reporting Person"

remote/foreign notarization regulatory

"securing the necessary remote/foreign notarization and processing the initial EDGAR access credentials"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for NIVF disclose about Lau Tsz Hin Vincent?

It states that Lau Tsz Hin Vincent is a newly appointed Independent Non-Executive Director of NewGenIvf Group Ltd and that this initial ownership report does not list any holdings or transactions in the company’s securities for him.

When was the new independent director of NIVF appointed?

The filing states that the Reporting Person, Lau Tsz Hin Vincent, was appointed as an Independent Non-Executive Director on June 8, 2026.

Are any NewGenIvf (NIVF) share transactions reported in this Form 3?

No. The Form 3’s transaction summary shows no buy, sell, acquire, dispose, or derivative transactions, and it reports zero shares bought, sold, or held in derivative form.

Does the Form 3 for NIVF indicate that the director holds any NIVF securities?

No. The structured data show no holding entries, meaning the Form 3 does not report any NewGenIvf Group Ltd securities as owned by the Reporting Person at the time of this initial statement.

Why was the NIVF Form 3 for the new director filed late?

The remarks explain it was filed late due to administrative and logistical delays within the company in obtaining remote/foreign notarization and processing the initial EDGAR access credentials (Form ID) for the new Reporting Person.

Does the NIVF Form 3 mention any Rule 10b5-1 trading plan?

No. The document-level indicator for Rule 10b5-1 is null, and the available information does not state that any transactions were conducted under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 08:01 AM EDT Accepted by SEC EDGAR 09/04/2026 - 08:00 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lau Tsz Hin Vincent

(Last) (First) (Middle)

4A PAK KIN BLDG, KOWLOON

(Street)

HONG KONG 999077

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/08/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed late due to administrative and logistical delays within the Company in securing the necessary remote/foreign notarization and processing the initial EDGAR access credentials (Form ID) for the newly appointed Reporting Person. The Reporting Person was appointed as an Independent Non-Executive Director on June 8, 2026.

No securities are beneficially owned.

	/s/ Lau Tsz Hin Vincent	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)